S100 immunophenotypes of uveal melanomas.
To determine whether ocular melanomas are immunophenotypically identical to cutaneous melanomas, 34 primary and metastatic choroidal melanomas representing all major histotypes defined by the Callender's classification, plus one melanoma of the iris and one conjunctival melanoma, were subjected to a panel of immunostains designed to distinguish anaplastic biopsies of cutaneous melanomas from carcinomas and lymphomas. All ocular melanomas were found to express the intermediate filament vimentin but not keratin, and all but 2 were melanotic by immunostaining. Thirty-three of 34 (97%) choroidal melanomas were strongly stained with a rabbit polyclonal antibody (P-S100) developed against the S100 protein family. In contrast, none of 14 spindle cell type primary lesions was stained with a monoclonal antibody (MAB-079) specific for both S100 alpha and S100 beta, the best-characterized S100 polypeptides. Furthermore, only 2 of 5 epithelioid and 3 of 10 mixed-cell-type melanomas were weakly reactive. Overall, 14.7% (5 of 29) were stained. In comparison, MAB079 stained 85% of all cutaneous melanomas. Five metastases of choroidal melanomas (spindle B, epithelioid, and mixed cell types) from different organ sites also were stained by P-S100 but not by MAB079. These findings were corroborated by immunostaining with another monoclonal antibody (MAB4D4) specific for S100 beta. Differential staining by the polyclonal but not the monoclonal antibodies suggests the possible presence of a variant S100 polypeptide(s) in choroidal melanomas. Since S100 alpha, S100 beta, and related proteins appear to be physiologically important, additional studies of these S100 proteins may shed light on the etiology or pathology of choroidal melanomas.
Kan-Mitchell
J
J
Department of Pathology, Norris Cancer Hospital and Research Institute, Los Angeles, California.
Rao
N
N
Albert
D M
DM
Van Eldik
L J
LJ
Taylor
C R
CR
D000911:Antibodies, Monoclonal; D016009:Chi-Square Distribution; D003230:Conjunctival Neoplasms / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D015811:Iris Neoplasms / Q000378:metabolism; D007633:Keratins / Q000378:metabolism; D008545:Melanoma / Q000276:immunology / Q000378:metabolism* / Q000556:secondary; D010641:Phenotype; D009418:S100 Proteins / Q000096:biosynthesis* / Q000276:immunology; D012878:Skin Neoplasms / Q000378:metabolism / Q000556:secondary; D014604:Uveal Neoplasms / Q000378:metabolism* / Q000556:secondary; D014746:Vimentin / Q000378:metabolism
D000911:Antibodies, Monoclonal; D009418:S100 Proteins; D014746:Vimentin; D007633:Keratins